Alexander D. Boiko

1.5k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

Alexander D. Boiko is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Alexander D. Boiko has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Alexander D. Boiko's work include Immunotherapy and Immune Responses (5 papers), Phagocytosis and Immune Regulation (3 papers) and Immune cells in cancer (2 papers). Alexander D. Boiko is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Phagocytosis and Immune Regulation (3 papers) and Immune cells in cancer (2 papers). Alexander D. Boiko collaborates with scholars based in United States, Germany and Spain. Alexander D. Boiko's co-authors include Olga V. Razorenova, Irving L. Weissman, Andrei V. Gudkov, Matt van de Rijn, Denise Johnson, Daphne P. Ly, Susan M. Swetter, Michael T. Longaker, Michael J. Kaplan and Paris D. Butler and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Alexander D. Boiko

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

2010 541 citations Alexander D. Boiko, Olga V. Razorenova et al. Nature profile →

Peers

Countries citing papers authored by Alexander D. Boiko

Since Specialization

Citations

This map shows the geographic impact of Alexander D. Boiko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander D. Boiko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander D. Boiko more than expected).

Fields of papers citing papers by Alexander D. Boiko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander D. Boiko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander D. Boiko. The network helps show where Alexander D. Boiko may publish in the future.

Co-authorship network of co-authors of Alexander D. Boiko

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander D. Boiko. A scholar is included among the top collaborators of Alexander D. Boiko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander D. Boiko. Alexander D. Boiko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesis 2024 ·Frontiers in Immunology ·(unknown), (unknown), Diego M. Marzese, Bethany Smith, Neil A. Bhowmick, Mark B. Faries, Omid Hamid, Alexander D. Boiko	1
2	Calreticulin is a Critical Cell Survival Factor in Malignant Neoplasms 2019 ·PLoS Biology ·Arum Han, Chen Li, (unknown), (unknown), Ian F. Smith, (unknown), Douglas R. Green, Alexander D. Boiko	29
3	CD271 is a molecular switch with divergent roles in melanoma and melanocyte development 2019 ·Scientific Reports ·Fabian V. Filipp, Chen Li, Alexander D. Boiko	16
4	Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signaling 2019 ·Proceedings of the National Academy of Sciences ·Chen Li, (unknown), (unknown), (unknown), (unknown), Fabian V. Filipp, Alexander D. Boiko	40
5	Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts 2016 ·Cell Reports ·(unknown), Arum Han, Anita Lakatos, Debashis Sahoo, Stephanie J. Hachey, Kipp Weiskopf, Andrew H. Beck, Irving L. Weissman, Alexander D. Boiko	60
6	Therapeutic implications of melanoma heterogeneity 2016 ·Experimental Dermatology ·Stephanie J. Hachey, Alexander D. Boiko	28
7	Isolation of Melanoma Tumor-Initiating Cells from Surgical Tissues 2012 ·Methods in molecular biology ·Alexander D. Boiko	11
8	VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration 2011 ·Proceedings of the National Academy of Sciences ·Olga V. Razorenova, Elizabeth Finger, Renata Colavitti, Sophia B. Chernikova, Alexander D. Boiko, Charles K. F. Chan, Adam J. Krieg, Barbara Bedogni, Edward L. LaGory, Irving L. Weissman, (unknown), Amato J. Giaccia	72
9	Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271 breakdown → 2010 ·Nature ·Alexander D. Boiko, Olga V. Razorenova, Matt van de Rijn, Susan M. Swetter, Denise Johnson, Daphne P. Ly, Paris D. Butler, George P. Yang, Ben‐Zion Joshua, Michael J. Kaplan, Michael T. Longaker, Irving L. Weissman	541
10	A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation 2006 ·Genes & Development ·Alexander D. Boiko, (unknown), Olga V. Razorenova, Vadim I. Krivokrysenko, Bryan Williams, Andrei V. Gudkov	118
11	Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells 2004 ·Proceedings of the National Academy of Sciences ·Tao Lu, Lyudmila G. Burdelya, (unknown), Alexander D. Boiko, Philip H. Howe, George R. Stark, Andrei V. Gudkov	84
12	Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence 2002 ·Genes & Development ·Xianghong Zou, Dipankar Ray, (unknown), Konstantin Christov, Alexander D. Boiko, Andrei V. Gudkov, Hiroaki Kiyokawa	119
13	Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response. 1998 ·PubMed ·(unknown), Alexander R. Kazarov, Alexander D. Boiko, (unknown), Igor B. Roninson, Andrei V. Gudkov	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact